Article
Combating the SARS-CoV-2 Omicron variant with non-Omicron neutralizing antibodies
2022-01-31
Abstract excerpt
The highly mutated and transmissible Omicron variant has provoked serious concerns over its decreased sensitivity to the current coronavirus disease 2019 (COVID-19) vaccines and evasion from most anti-severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) neutralizing antibodies (NAbs). In this study, we explored the possibility of combatting the Omicron variant by constructing bispecific antibodies based on...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 5e6f6175-c01e-536c-9eb5-492bf75e937e
- DOI
- 10.1101/2022.01.30.478305
